DWS Health and Wellness A (SUHAX)
34.40
-0.18 (-0.52%)
USD |
Jun 30 2022
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 1.08% | 288.42M | 0.00% | 36.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| -25.27M | -5.04% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks long-term growth of capital. Under normal circumstances, the fund will invest at least 80% of net assets, plus the amount of any borrowings for investment purposes, in equity securities of companies in the health care and wellness sectors. It invests primarily in securities of U.S. companies, but may invest in foreign companies as well. The fund may invest in companies of any size. While the fund invests mainly in common stocks, it may also invest up to 20% of total assets in U.S. Treasury and U.S. agency debt obligations. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | SCHLX |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | S&P 1500 Health Care TR |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | DWS |
| Prospectus Benchmark Index | |
| S&P 500 TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Leefin Lai | 20.43 yrs |
| Michael Sesser | 8.00 yrs |
| Peter Barsa | 8.00 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
44
-25.27M
-3.341B
Category Low
10.11B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of May 31, 2022
Performance Versus Category
As of June 30, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of June 30, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| UnitedHealth Group Inc | 8.64% | 503.93 | -1.89% |
| Johnson & Johnson | 5.94% | 177.47 | -0.02% |
| Eli Lilly and Co | 4.71% | 318.66 | -1.72% |
| Thermo Fisher Scientific Inc | 4.24% | 536.28 | -1.29% |
| Pfizer Inc | 3.58% | 51.51 | -1.75% |
| Abbott Laboratories | 3.03% | 108.07 | -0.53% |
| Bristol-Myers Squibb Co | 2.65% | 76.08 | -1.19% |
| AstraZeneca PLC ADR | 2.52% | 64.56 | -2.29% |
| Boston Scientific Corp | 2.51% | 37.23 | -0.11% |
| AbbVie Inc | 2.42% | 152.71 | -0.29% |
Basic Info
| Investment Strategy | |
| The investment seeks long-term growth of capital. Under normal circumstances, the fund will invest at least 80% of net assets, plus the amount of any borrowings for investment purposes, in equity securities of companies in the health care and wellness sectors. It invests primarily in securities of U.S. companies, but may invest in foreign companies as well. The fund may invest in companies of any size. While the fund invests mainly in common stocks, it may also invest up to 20% of total assets in U.S. Treasury and U.S. agency debt obligations. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | SCHLX |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | S&P 1500 Health Care TR |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | DWS |
| Prospectus Benchmark Index | |
| S&P 500 TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Leefin Lai | 20.43 yrs |
| Michael Sesser | 8.00 yrs |
| Peter Barsa | 8.00 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (6-30-22) | 0.00% |
| 30-Day SEC Yield (6-1-22) | Upgrade |
| 7-Day SEC Yield (6-28-22) | Upgrade |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 25.30 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of April 30, 2022
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 12/29/2000 |
| Last Annual Report Date | 5/31/2021 |
| Last Prospectus Date | 10/1/2021 |
| Share Classes | |
| SCHLX | S |
| SUHCX | C |
| SUHIX | Inst |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |